Exercise as Maintenance Therapy in Advanced Lung Cancer
Key facts
- Who runs it
- Indiana University
- Where
- Indianapolis, United StatesSee the 3 sites
- Trial code
- Status
- Terminated
- People taking part
- 2 people enrolled
- Started
- 15 Oct 2024
- Ended
- 4 Jun 2025
- Type of study
- Interventional, 2 groupsOne group gets no study treatment, for comparison.
- Treatments tested
- Exercise Intervention
- Record updated
- 27 April 2026
- Why it stopped
- trial stopped due to low accrual
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 8 criteriaShow less
Who can take part
- Age ≥ 18 years
- Known diagnosis of locally advanced (stage III) or metastatic NSCLC
- Patient is currently receiving maintenance immunotherapy for at least 1 month and planned for at least 3 additional months of therapy; Patients receiving maintenance therapy refers to patients with stable disease or partial response to therapy, including patients who have had a history of disease progression but are currently stable or responding to a different therapy; Patients previously receiving chemotherapy are eligible as long as at least one month has elapsed since completing chemotherapy. Those currently receiving chemotherapy are not eligible
- Patient is willing and able to participate in a supervised home-based exercise program as determined by the MOVE program; a.Participants must have internet access and equipment to participate in virtual exercise
- ECOG performance status of 0-2
Who cannot take part
- Medical co-morbidities that preclude patient from participating in supervised exercise, including but not limited to:; Advanced heart failure; Advanced respiratory disease requiring home oxygen use; Uncontrolled psychiatric disorders; History of fragility fracture
- Already meeting exercise guidelines and participating in at least 150 minutes of moderate or vigorous exercise per IPAQ
- Unable to participate in the supervised home-based exercise program as determined by the MOVE program
Where in United States
- Indiana University Health Methodist HospitalIndianapolis, United States
- Indiana University Melvin & Bren Simon Comprehensive Cancer CenterIndianapolis, United States
- Sidney and Lois Eskenazi HospitalIndianapolis, United States
About the trial
What the trial wants to find out
The purpose of this study is to examine how a multimodality (having or using a variety of methods to do something) exercise intervention may improve survival, function, and quality of life in participants with advanced lung cancer.
The 2 groups in the trial
- Exercise InterventionTreatment being tested
Eligible and consented participants randomized to the exercise arm will work with an exercise trainer three times weekly for 12 weeks. Training sessions will be delivered virtually using HIPPA Complaint IU Health Zoom. These sessions will last 60 minutes and include cardiovascular exercise, resistance training, and balance or stretching exercise. The participants will be able to use any equipment they already have at home but will be provided a heart monitor and a set of resistance bands. All sessions will have a moderate-intensity training goal, defined as 40-80% of heart rate reserve (HRR). Cardiovascular exercise will include any at-home equipment available to the participants or follow a Tabata-style program. Resistance training will include a full body workout, emphasizing all major muscle groups. Trainers will progress or regress intensity levels based on the participant's rate of perceived exertion (RPE), heart rate, and individual response during each session.
- Usual CareNo study treatment, for comparison
Participants randomized to usual care arm will receive care per their treatment team. Usual care participants are encouraged to exercise but will not be provided components of the intervention. Participants in the usual care arm will be given usual care handouts at baseline.
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Record updated
- 27 April 2026